Case: Patents/Enablement (Fed. Cir.)

The Federal Circuit affirmed the decision of the Patent Trial and Appeal Board that claims of a patent application that discloses using ribavirin among other medications for the treatment of certain respiratory conditions are unpatentable for lack of enablement. The court said that substantial evidence supports the board’s fact findings underlying its conclusion that practicing the full scope of the claimed range would require undue experimentation.